Strive Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Strive Asset Management's LLY Position: Q4 2025 in Review
Strive Asset Management sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 359 shares — an estimated $274K sold.
Strive Asset Management first reported a position in LLY in Q4 2024 and held it in 4 quarters. The position peaked at $621K in Q1 2025. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.
- Strive Asset Management reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
- Strive Asset Management sold 359 Eli Lilly shares in Q4 2025, an estimated $274K.
- Strive Asset Management first reported a position in Eli Lilly in Q4 2024 and held it in 4 quarters.
- Strive Asset Management's Eli Lilly position peaked at $621K in Q1 2025.
- 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.
Based on Strive Asset Management's 13F filing for Q4 2025.